• 896 Citations
  • 13 h-Index
20042019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where T. Szamosi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 34 Similar Profiles
Crohn Disease Medicine & Life Sciences
Inflammatory Bowel Diseases Medicine & Life Sciences
Biosimilar Pharmaceuticals Medicine & Life Sciences
Ulcerative Colitis Medicine & Life Sciences
Biological Therapy Medicine & Life Sciences
Azathioprine Medicine & Life Sciences
Hungary Medicine & Life Sciences
Antibodies Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2004 2019

  • 896 Citations
  • 13 h-Index
  • 23 Article

Anti-TNF dose escalation and drug sustainability in Crohn's disease: Data from the nationwide administrative database in Hungary

Kósa, F., Kunovszki, P., Borsi, A., Iliás, Á., Palatka, K., Szamosi, T., Vincze, Á., Molnár, T. & Lakatos, P. L., Jan 1 2019, (Accepted/In press) In : Digestive and Liver Disease.

Research output: Contribution to journalArticle

Hungary
Crohn Disease
Databases
Biosimilar Pharmaceuticals
Pharmaceutical Preparations
4 Citations (Scopus)

Outcomes of Patients With Inflammatory Bowel Diseases Switched From Maintenance Therapy With a Biosimilar to Remicade

Ilias, A., Szanto, K., Gonczi, L., Kurti, Z., Golovics, P. A., Farkas, K., Schafer, E., Szepes, Z., Szalay, B., Vincze, A., Szamosi, T., Molnar, T. & Lakatos, P. L., Nov 2019, In : Clinical Gastroenterology and Hepatology. 17, 12, p. 2506-2513.e2

Research output: Contribution to journalArticle

Biosimilar Pharmaceuticals
Inflammatory Bowel Diseases
Crohn Disease
Ulcerative Colitis
Therapeutics
23 Citations (Scopus)

Prediction of Short- and Medium-term Efficacy of Biosimilar Infliximab Therapy. Do Trough Levels and Antidrug Antibody Levels or Clinical And Biochemical Markers Play the More Important Role?

Gonczi, L., Vegh, Z., Golovics, P. A., Rutka, M., Gecse, K. B., Bor, R., Farkas, K., Szamosi, T., Bene, L., Gasztonyi, B., Kristóf, T., Lakatos, L., Miheller, P., Palatka, K., Papp, M., Patai, Á., Salamon, Á., Tóth, G. T., Vincze, A., Biro, E. & 5 others, Lovasz, B. D., Kurti, Z., Szepes, Z., Molnár, T. & Lakatos, P., Jun 1 2017, In : Journal of Crohn's & colitis. 11, 6, p. 697-705 9 p.

Research output: Contribution to journalArticle

Biosimilar Pharmaceuticals
Area Under Curve
Biomarkers
Ulcerative Colitis
Crohn Disease